Finanzwire Finanzwire
Basculer en Français
11008 Companies
241201 Keywords
169756 Articles
129838 Press releases
Headlines Articles Press releases ABIONYX Remove
  1. Home
  2. Companies
  3. ABIONYX
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/19/2024 at 21:20, 2 years 2 months ago

    ABIONYX announces a capital increase without preferential subscription rights

    Biotechnology Actions United States Increase In Capital Sepsis
  • PRESS RELEASE

    published on 06/19/2024 at 21:15, 2 years 2 months ago

    Inside Information / Other news releases

    ABIONYX announces capital increase of c.€3.4 million with share issuance and warrants, strengthening financial position for Sepsis and US development, supported by ORSAY 53 investment company
    Capital Increase Share Issuance ABIONYX Sepsis Development ORSAY 53
    Logo of ABIONYX
  • BRIEF

    published on 06/13/2024 at 19:53, 2 years 3 months ago

    ABIONYX Pharma Receives FDA Approval for New Sepsis Study

    FDA Clinical Study ABIONYX Pharma Sepsis CER-001
  • PRESS RELEASE

    published on 06/13/2024 at 19:48, 2 years 3 months ago

    Inside Information / Other news releases

    ABIONYX Pharma completes successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial in Sepsis, marking significant progress in developing innovative therapy
    FDA ABIONYX Pharma Sepsis CER-001 Pre-IND Meeting
    Logo of ABIONYX
Previous page
1 ... 8 9
Accesswire
  • Published on 09/16/2026 at 23:45, 10 hours 1 minute ago

    Galway Metals Settles Claim by Former Employee with Cash and Share Payments

  • Published on 09/16/2026 at 21:30, 12 hours 16 minutes ago

    Torq Completes $1.7 Million Private Placement

  • Published on 09/16/2026 at 16:55, 16 hours 51 minutes ago

    CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project

  • Published on 09/16/2026 at 15:00, 18 hours 46 minutes ago

    2026 Canada's Top 40 Under 40(R) Honourees Announced

  • Published on 09/16/2026 at 14:00, 19 hours 46 minutes ago

    Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update

View all ACCESSWIRE
EQS Group
  • Published on 09/17/2026 at 09:30, 16 minutes ago

    Allane Mobility Group and DEKRA expand their network of return locations

  • Published on 09/17/2026 at 09:28, 17 minutes ago

    KNDS THL20 TURRETS SELECTED FOR INDIA’S NEW LIGHT COMBAT HELICOPTER PROGRAM

  • Published on 09/17/2026 at 09:00, 46 minutes ago

    Encavis completes EUR 282 million non-recourse project financing for 351 MW solar PV portfolio in Italy

  • Published on 09/17/2026 at 09:00, 46 minutes ago

    Removal - UDI STEERS Notes Series 2007-1

  • Published on 09/17/2026 at 09:00, 46 minutes ago

    Grünenthal announces pricing of €850 million of bonds

View all EQS
Les Echos
  • Published on 09/16/2026 at 20:46, 12 hours 59 minutes ago

    LNA SANTE : 2026 First Half Results

  • Published on 09/16/2026 at 17:45, 16 hours 1 minute ago

    5th edition of “On the way up” show

  • Published on 09/16/2026 at 17:45, 16 hours 1 minute ago

    Report on share repurchases from 9 to 15 September 2026

  • Published on 09/16/2026 at 07:00, 1 day 2 hours ago

    bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification

  • Published on 09/15/2026 at 18:00, 1 day 15 hours ago

    Report on the Combined General Meeting of the 10th of September 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy